End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.91 CNY | -1.75% | -10.66% | -34.75% |
05-10 | China Grants Clinical Trial Approval to Bio-Thera's Anti-Tumor Combination Therapy | MT |
04-29 | Bio-Thera Solutions, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.75% | 1.54B | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- 688177 Stock
- News Bio-Thera Solutions, Ltd.
- China Grants Clinical Trial Approval to Bio-Thera's Anti-Tumor Combination Therapy